- Filed
- Feb 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 19, 2025 | 359.85M sh |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $6.54B |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $6.62B |
| Current Assets | FY 2024 · Dec 31, 2023 | $7.11B |
| Total Assets | FY 2024 · Dec 31, 2023 | $7.28B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 348.04M sh |
| Capex | FY 2024 · Dec 31, 2022 | $10.5M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $83.96M |
| Cash And Equivalents | FY 2024 · Dec 31, 2022 | $543.3M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$0.03 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$0.03 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $90.01M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $115.04M |
| Net Income | FY 2024 · Dec 31, 2022 | −$11.97M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$22.21M |
| Revenue restated | FY 2024 · Dec 31, 2022 | $563.57M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $487.07M |